Atlas Trials

International Vaccine Institute

47 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch International Vaccine Institute

RecordFirmDate
Safety and Immunogenicity Study of the DuoChol Oral Cholera Vaccine in Healthy Participants (NCT07270796)International Vaccine Institute2027-01-01
Safety and Immunogenicity Study of IP-QSV Vaccine in Healthy Adults/Adolescents, Children and Infants (NCT07666750)International Vaccine Institute2026-07-01
Strengthening HPV Immunization Through EPI Leveraged Delivery (NCT07377656)International Vaccine Institute2026-04-30
Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children (NCT07509047)International Vaccine Institute2026-01-13
Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus (NCT07304284)International Vaccine Institute2025-10-31
Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-typhoidal Salmonella Disease (NCT07416461)International Vaccine Institute2025-10-27
Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC) (NCT07093489)International Vaccine Institute2025-09-30
Hepatitis B Vaccine Delivered Trans-dermally by MAP (NCT06800131)International Vaccine Institute2025-02-05
Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women (NCT05808166)International Vaccine Institute2024-05-02
Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children (NCT06306196)International Vaccine Institute2024-04-04
Global Burden Estimation of Human Papillomavirus (GLOBE-HPV) (NCT06129253)International Vaccine Institute2023-11-23
Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults (NCT05559983)International Vaccine Institute2022-12-05
Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique (NCT05362682)International Vaccine Institute2022-02-24
Effectiveness of a Typhoid Conjugate Vaccine in DRC (NCT05119426)International Vaccine Institute2022-02-11
Mix and Match Heterologous Prime-Boost Study Using Approved COVID-19 Vaccines (NCT04998240)International Vaccine Institute2021-12-29
Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™ (NCT04760236)International Vaccine Institute2021-10-06
Efficacy, Immunogenicity and Safety of BBIBP-CorV Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. (NCT04984408)International Vaccine Institute2021-10-01
Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (NCT04852185)International Vaccine Institute2021-08-24
TyVECO: Surveillance Protocol (NCT05562102)International Vaccine Institute2021-08-09
Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 (NCT04447781)International Vaccine Institute2020-07-15
Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III) (NCT04204096)International Vaccine Institute2020-02-04
Immune Non-inferiority and Safety of a Vi-DT Typhoid Conjugate Vaccine (NCT03933098)International Vaccine Institute2019-11-15
Effectiveness of Single Dose or Two Doses of Bivalent HPV Vaccine in Thailand (NCT03747770)International Vaccine Institute2018-12-17
Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine (NCT03527355)International Vaccine Institute2018-04-18

Track International Vaccine Institute automatically

Every clearance here is in the API, with alerts when new ones post.